Phase II Trial with High-Dose Elliptinium Acetate in Metastatic Renal Cell Carcinoma

G. Piot; J.P. Droz; C. Theodore; M. Ghosn; J. Rouëssé; J.L. Amiel

doi:10.1159/000226643

Phase II Trial with High-Dose Elliptinium Acetate in Metastatic Renal Cell Carcinoma

Oncology ◽

10.1159/000226643 ◽

1988 ◽

Vol 45 (5) ◽

pp. 371-372 ◽

Cited By ~ 4

Author(s):

G. Piot ◽

J.P. Droz ◽

C. Theodore ◽

M. Ghosn ◽

J. Rouëssé ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

High Dose

Download Full-text

Hybrid High-Dose Bolus/Continuous Infusion Interleukin-2 in Patients with Metastatic Renal Cell Carcinoma: A Phase II Trial of the National Biotherapy Study Group

Cancer Biotherapy & Radiopharmaceuticals ◽

10.1089/cbr.1997.12.5 ◽

1997 ◽

Vol 12 (1) ◽

pp. 5-11 ◽

Cited By ~ 26

Author(s):

Robert O. Dillman ◽

Michael C. Wiemann ◽

Martin J. Bury ◽

Curtis Church ◽

Carol DePriest

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Continuous Infusion ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interleukin 2 ◽

High Dose ◽

Study Group

Download Full-text

Phase II trial of Modified Vaccinia Ankara (MVA) virus expressing 5T4 and high dose Interleukin-2 (IL-2) in patients with metastatic renal cell carcinoma

Journal of Translational Medicine ◽

10.1186/1479-5876-7-2 ◽

2009 ◽

Vol 7 (1) ◽

Cited By ~ 51

Author(s):

Howard L Kaufman ◽

Bret Taback ◽

William Sherman ◽

Dae Won Kim ◽

William H Shingler ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interleukin 2 ◽

High Dose

Download Full-text

HYBRID HIGH-DOSE BOLUS/CONTINUOUS INFUSION INTERLEUKIN-2 IN PATIENTS WITH METASTATIC RENAL CELL CARCINOMA: A PHASE II TRIAL OF THE NATIONAL BIOTHERAPY STUDY GROUP

Journal of Immunotherapy ◽

10.1097/00002371-199611000-00015 ◽

1996 ◽

Vol 19 (6) ◽

pp. 457

Author(s):

R O Dillman ◽

M C Wiemann ◽

M J Bury ◽

C Church ◽

C DePriest

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Continuous Infusion ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interleukin 2 ◽

High Dose ◽

Study Group

Download Full-text

Outcome and Immune Correlates of a Phase II Trial of High-Dose Interleukin-2 and Stereotactic Ablative Radiotherapy for Metastatic Renal Cell Carcinoma

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-21-2083 ◽

2021 ◽

Author(s):

Raquibul Hannan ◽

Osama Mohamad ◽

Alberto Diaz de Leon ◽

Subrata Manna ◽

Laurentiu M. Pop ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Interleukin 2 ◽

Stereotactic Ablative Radiotherapy ◽

High Dose ◽

Immune Correlates

Download Full-text

Phase II Trial of Low Dose γ -Interferon in Metastatic Renal Cell Carcinoma

The Journal of Urology ◽

10.1016/s0022-5347(17)32587-9 ◽

1994 ◽

Vol 152 (3) ◽

pp. 841-845 ◽

Cited By ~ 32

Author(s):

Julie A. Ellerhorst ◽

Robert G. Kilbourn ◽

Robert J. Amato ◽

Alexander A. Zukiwski ◽

Elaine Jones ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Low Dose ◽

Phase Ii Trial ◽

Γ Interferon

Download Full-text

An early phase II trial of S-1 in Japanese patients with cytokine-refractory metastatic renal cell carcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-010-1262-8 ◽

2010 ◽

Vol 66 (6) ◽

pp. 1065-1070 ◽

Cited By ~ 6

Author(s):

Seiji Naito ◽

Taiji Tsukamoto ◽

Michiyuki Usami ◽

Hiroyuki Fujimoto ◽

Hideyuki Akaza

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Early Phase ◽

Phase Ii Trial ◽

Japanese Patients

Download Full-text

A phase II trial of first-line sorafenib in patients with metastatic renal cell carcinoma unwilling to receive or with early intolerance to immunotherapy: SOGUG Study 06-01

Clinical & Translational Oncology ◽

10.1007/s12094-010-0544-2 ◽

2010 ◽

Vol 12 (7) ◽

pp. 503-508 ◽

Cited By ~ 9

Author(s):

Joaquim Bellmunt ◽

Pablo Maroto-Rey ◽

José M. Trigo ◽

Joan Carles ◽

Vicente Guillem ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

First Line ◽

To Receive

Download Full-text

Granulocyte-Macrophage-Colony Stimulating Factor in Metastatic Renal Cell Carcinoma. A Phase II Trial

The Journal of Urology ◽

10.1016/s0022-5347(01)62035-4 ◽

1999 ◽

Vol 161 (2) ◽

pp. 733-733

Author(s):

B.I. Rini ◽

W.M. Stadler ◽

R.T. Spielberger ◽

M.J. Ratain ◽

N.J. Vogelzang

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Colony Stimulating Factor ◽

Macrophage Colony Stimulating Factor ◽

Macrophage Colony ◽

Stimulating Factor

Download Full-text

Phase II Trial of Capecitabine and Weekly Docetaxel in Metastatic Renal Cell Carcinoma

Urology ◽

10.1016/j.urology.2008.05.032 ◽

2008 ◽

Vol 72 (4) ◽

pp. 898-902 ◽

Cited By ~ 10

Author(s):

Shanthi Marur ◽

James Eliason ◽

Lance K. Heilbrun ◽

Brenda Dickow ◽

Daryn W. Smith ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Weekly Docetaxel

Download Full-text

A phase II trial of palliative radiotherapy for metastatic renal cell carcinoma

Cancer ◽

10.1002/cncr.21410 ◽

2005 ◽

Vol 104 (9) ◽

pp. 1894-1900 ◽

Cited By ~ 60

Author(s):

Justin Lee ◽

David Hodgson ◽

Edward Chow ◽

Andrea Bezjak ◽

Pamela Catton ◽

...

Keyword(s):

Renal Cell Carcinoma ◽

Cell Carcinoma ◽

Phase Ii ◽

Metastatic Renal Cell Carcinoma ◽

Renal Cell ◽

Phase Ii Trial ◽

Palliative Radiotherapy

Download Full-text